Menassie Taddese
Vermögen: 148 412 $ am 30.09.2026
Vermögen: 148 412 $ am 30.09.2026
Mr. Menassie Taddese is an Independent Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Xeris Biopharma Holdings, Inc. and Medexus Pharmaceuticals, Inc. Mr. Taddese was previously employed as a President-Emerging Markets by Viatris, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.09.2025 | 42’869 ( 0.14% ) | 148 412 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 06.02.2023 |
| XERIS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 02.11.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01.12.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen